These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8516490)

  • 1. Calcium antagonists and renal protection.
    Neumayer HH; Gellert J; Luft FC
    Ren Fail; 1993; 15(3):353-8. PubMed ID: 8516490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal protection with the calcium antagonists.
    Neumayer HH; Kunzendorf U
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S11-8. PubMed ID: 1723449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists and renal failure progression.
    Robles NR
    Ren Fail; 2008; 30(3):247-55. PubMed ID: 18350443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal haemodynamic and protective effects of calcium antagonists in hypertension.
    Zanchi A; Brunner HR; Waeber B; Burnier M
    J Hypertens; 1995 Dec; 13(12 Pt 1):1363-75. PubMed ID: 8866898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the renal hemodynamic response to vasoconstrictors by calcium antagonists.
    Loutzenhiser R; Epstein M
    Am J Nephrol; 1987; 7 Suppl 1():7-16. PubMed ID: 3442293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium antagonists and renal protection.
    Rodicio JL; Morales JM; Alcázar JM; Ruilope LM
    J Hypertens Suppl; 1993 Mar; 11(1):S49-53. PubMed ID: 8483023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological basis for use of calcium antagonists in hypertension.
    Scriabine A; Kazda S
    Magnesium; 1989; 8(5-6):253-65. PubMed ID: 2693846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium antagonists and the kidney. Implications for renal protection.
    Epstein M
    Am J Hypertens; 1993 Jul; 6(7 Pt 2):251S-259S. PubMed ID: 8398009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal protective effects of calcium antagonists].
    Musialik D; Raszeja-Wanic B; Tylarski A
    Pol Merkur Lekarski; 1996 Oct; 1(4):266-70. PubMed ID: 9156942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists and the renal hemodynamic response to vasoconstrictors.
    Loutzenhiser R; Epstein M
    Ann N Y Acad Sci; 1988; 522():771-84. PubMed ID: 3377380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal hemodynamic effects of calcium antagonists.
    Loutzenhiser RD; Epstein M; Hayashi K
    Am J Cardiol; 1989 Sep; 64(11):41F-45F. PubMed ID: 2782270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists and the kidney. Implications for renal protection.
    Epstein M
    Am J Hypertens; 1991 Jul; 4(7 Pt 2):482S-486S. PubMed ID: 1910641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists and the kidney: future therapeutic perspectives.
    Epstein M
    Am J Kidney Dis; 1993 Jun; 21(6 Suppl 3):16-25. PubMed ID: 8503430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of calcium antagonists on renal hemodynamics and progression of nondiabetic chronic renal disease.
    ter Wee PM; De Micheli AG; Epstein M
    Arch Intern Med; 1994 Jun; 154(11):1185-202. PubMed ID: 8203987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are calcium antagonists of value in ameliorating the course of chronic renal disease?
    Luft FC; Johnston CI
    Kidney Int Suppl; 1992 May; 36():S114-8. PubMed ID: 1614061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification by dihydropyridine-type calcium antagonists of the renal hemodynamic response to vasoconstrictors.
    Loutzenhiser R; Epstein M; Horton C
    J Cardiovasc Pharmacol; 1987; 9 Suppl 1():S70-5. PubMed ID: 2441189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.